SMT201400094B - Formulazioni di acido deossicolico e sali di esso - Google Patents

Formulazioni di acido deossicolico e sali di esso

Info

Publication number
SMT201400094B
SMT201400094B SM201400094T SM201400094T SMT201400094B SM T201400094 B SMT201400094 B SM T201400094B SM 201400094 T SM201400094 T SM 201400094T SM 201400094 T SM201400094 T SM 201400094T SM T201400094 B SMT201400094 B SM T201400094B
Authority
SM
San Marino
Prior art keywords
salts
acid formulations
deoxycolic
deoxycolic acid
formulations
Prior art date
Application number
SM201400094T
Other languages
English (en)
Inventor
Robert M Moriarty
Robert Emil Hodge
Jeffrey Douglas Webster
Original Assignee
Kythera Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kythera Biopharmaceuticals Inc filed Critical Kythera Biopharmaceuticals Inc
Publication of SMT201400094B publication Critical patent/SMT201400094B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
SM201400094T 2011-08-23 2014-07-16 Formulazioni di acido deossicolico e sali di esso SMT201400094B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11178538.2A EP2561876B1 (en) 2011-08-23 2011-08-23 Formulations of Deoxycholic Acid and Salts Thereof

Publications (1)

Publication Number Publication Date
SMT201400094B true SMT201400094B (it) 2014-11-10

Family

ID=44651163

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201400094T SMT201400094B (it) 2011-08-23 2014-07-16 Formulazioni di acido deossicolico e sali di esso

Country Status (11)

Country Link
EP (4) EP2735310B1 (it)
CY (1) CY1115372T1 (it)
DK (2) DK3305298T3 (it)
ES (3) ES2478447T3 (it)
HR (1) HRP20140676T1 (it)
HU (1) HUE046047T2 (it)
PL (2) PL3305298T3 (it)
PT (2) PT3305298T (it)
RS (1) RS53419B (it)
SI (1) SI2561876T1 (it)
SM (1) SMT201400094B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
EP2675460A4 (en) 2011-02-18 2014-07-09 Kythera Biopharmaceuticals Inc TREATMENT OF FAT TISSUE UNDER CHIN
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
CN108366975A (zh) * 2015-11-04 2018-08-03 凯瑟拉生物制药有限公司 使用脱氧胆酸和其盐对堆积的脂肪的治疗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
US6417179B1 (en) * 1998-10-13 2002-07-09 Craig G. Burkhart Ear wax solution
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
ES2660172T3 (es) 2004-05-19 2018-03-21 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Composición inyectable que comprende desoxicolato de sodio
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20090317376A1 (en) 2005-06-06 2009-12-24 Georgetown University Medical School Compositions And Methods For Lipo Modeling
TW201011755A (en) 2008-09-10 2010-03-16 Skymedi Corp Flash memory system and its data recovery method

Also Published As

Publication number Publication date
ES2478447T3 (es) 2014-07-22
EP2561876A1 (en) 2013-02-27
PT3305298T (pt) 2019-07-29
HUE046047T2 (hu) 2020-01-28
HRP20140676T1 (hr) 2014-10-10
PL3305298T3 (pl) 2020-02-28
PL2561876T3 (pl) 2014-09-30
DK3305298T3 (da) 2019-07-29
EP3305298B1 (en) 2019-05-01
ES2738500T3 (es) 2020-01-23
ES2655465T3 (es) 2018-02-20
EP2735310B1 (en) 2017-10-11
CY1115372T1 (el) 2017-01-04
PT2561876E (pt) 2014-07-18
RS53419B (en) 2014-12-31
EP2735310A1 (en) 2014-05-28
EP3305298A1 (en) 2018-04-11
EP3511007A1 (en) 2019-07-17
DK2561876T3 (da) 2014-07-21
EP2561876B1 (en) 2014-04-16
SI2561876T1 (sl) 2014-08-29

Similar Documents

Publication Publication Date Title
SMT201600389B (it) Sali di diamminio di fenotiazina e loro uso
SMT201500037B (it) Sali di 2,3-diidroimidazoÄ1,2-cÜchinazolina sostituiti
CR20130677A (es) FORMULACIÓN PARA ANTICUERPO ANTI-a4ß7
DK2685832T3 (da) Stabiliserede hypohalogensyreopløsninger
SMT201600272B (it) Diidropiridinoni e piperidinoni arilici come inibitori di mgat2
DK3091029T3 (da) Anti-IL13-antistofformuleringer
BR112013033444A2 (pt) formulações para terapia de ferida
DK2623507T3 (da) Morpholinonukleinsyrederivat
DK2562155T3 (da) Hydroxaminsyrederivat
DK3050972T3 (da) Fremgangsmåder til fremstilling af eicosapentaensyre i thraustochytrider
BR112014009503A2 (pt) formulações antimicrobianas com ácido pelargônico
DK3002135T3 (da) Bugseringsenhed
CO6870048A2 (es) Formulación herbicida mejorada
CO6940426A2 (es) Formulaciones farmacéuticas
BR112014000015A2 (pt) formulação
ZA201401027B (en) Formulations of deoxycholic acid and salts thereof
CO6842021A2 (es) Análogos de ácido epoxieicosatrienoico y métodos para elaborarlosy utilizarlos
ITMI20110480A1 (it) Procedimento per la preparazione di lapatinib e suoi sali
IT1404486B1 (it) Macchina seminatrice semovente di piccole dimensioni
DK2704978T3 (da) Selvdrevet vogn
SMT201400094B (it) Formulazioni di acido deossicolico e sali di esso
DK2588615T3 (da) Selv-deleterende plasmid
FR2978964B1 (fr) Composition vaccinale anti-il-6
SMT201600353B (it) Sali di acido solfonico di imidazoli eterociclilammide-sostituiti
SMT201600071B (it) Derivato di acido pirrolidina-3-ilacetico